Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Morgan

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Academic Radiology|January 21, 2014
Preoperative mapping of nonmelanoma skin cancer using spatial frequency domain and ultrasound imagingDaniel J Rohrbach, Daniel Muffoletto, Jonathan Huihui, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Photochemistry and Photobiology|November 10, 2005
Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacyAndrew Rosenfeld, Janet Morgan, Lalit N Goswami, et al.
Cancer Research|March 18, 2004
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumorsBarbara W Henderson, Sandra O Gollnick, John W Snyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2Weiguo Liu, Maria R Baer, Mary Jo Bowman, et al.
Journal of Medicinal Chemistry|September 25, 2014
Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cellsJacqueline E Hill, Michelle K Linder, Kellie S Davies, et al.
Journal of the American Chemical Society|June 26, 2003
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapyIndrajit Roy, Tymish Y Ohulchanskyy, Haridas E Pudavar, et al.
Molecular Pharmaceutics|June 28, 2011
Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacyAvinash Srivatsan, Manivannan Ethirajan, Suresh K Pandey, et al.
Bioconjugate Chemistry|April 15, 2010
Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacyLalit N Goswami, William H White, Joseph A Spernyak, et al.
Journal of Medicinal Chemistry|December 4, 2003
Synthesis, comparative photosensitizing efficacy, human serum albumin (site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vic-dihydroxybacteriochlorinsGuolin Li, Andrew Graham, Yihui Chen, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Academic Radiology|January 21, 2014
Preoperative mapping of nonmelanoma skin cancer using spatial frequency domain and ultrasound imagingDaniel J Rohrbach, Daniel Muffoletto, Jonathan Huihui, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Photochemistry and Photobiology|November 10, 2005
Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacyAndrew Rosenfeld, Janet Morgan, Lalit N Goswami, et al.
Cancer Research|March 18, 2004
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumorsBarbara W Henderson, Sandra O Gollnick, John W Snyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2Weiguo Liu, Maria R Baer, Mary Jo Bowman, et al.
Journal of Medicinal Chemistry|September 25, 2014
Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cellsJacqueline E Hill, Michelle K Linder, Kellie S Davies, et al.
Journal of the American Chemical Society|June 26, 2003
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapyIndrajit Roy, Tymish Y Ohulchanskyy, Haridas E Pudavar, et al.
Molecular Pharmaceutics|June 28, 2011
Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacyAvinash Srivatsan, Manivannan Ethirajan, Suresh K Pandey, et al.
Bioconjugate Chemistry|April 15, 2010
Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacyLalit N Goswami, William H White, Joseph A Spernyak, et al.
Journal of Medicinal Chemistry|December 4, 2003
Synthesis, comparative photosensitizing efficacy, human serum albumin (site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vic-dihydroxybacteriochlorinsGuolin Li, Andrew Graham, Yihui Chen, et al.
Pageof 4